Company Filing History:
Years Active: 2010-2013
Title: Inventor Christian Andrew Baumann: Pioneering Innovations in Oncology
Introduction
Christian Andrew Baumann is an esteemed inventor based in Exton, Pennsylvania. His remarkable contributions to the field of oncology through innovative research are highlighted by his four patents, which focus on enhancing treatment methods for cell proliferative disorders.
Latest Patents
One of Baumann's latest patents is centered on the "Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor." This invention proposes a method for inhibiting FLT3 tyrosine kinase activity or expression. It aims to reduce FLT3 kinase activity in a patient, thereby providing potential prophylactic and therapeutic solutions for individuals susceptible to disorders related to FLT3.
Another significant patent involves "Alkylquinoline and alkylquinazoline kinase modulators." This invention details the use of certain compounds as protein tyrosine kinase modulators, specifically targeting inhibition of FLT3, c-kit, and TrkB. The compounds are designed to combat cell proliferative disorders and are integral to developing therapeutic pharmaceuticals aimed at treating cancer and similar conditions.
Career Highlights
Christian Andrew Baumann has worked with reputable companies such as Janssen Pharmaceutica NV and Mitsubishi Tanabe Pharma Corporation. His work in these organizations has significantly contributed to the advancement of therapies aimed at tackling serious health issues, particularly in the field of oncology.
Collaborations
Throughout his career, Baumann has collaborated with notable professionals such as Robert W. Tuman and Dana L. Johnson. These partnerships have fostered innovation and have been pivotal in his research endeavors, leading to the successful development of impactful therapies.
Conclusion
Christian Andrew Baumann's innovative contributions to medical science stand as a testament to his dedication and expertise. With a focus on addressing cell proliferative disorders, his inventions have the potential to significantly change treatment landscapes and improve patient outcomes in oncology.